The Evolution of Radionanotargeting towards Clinical Precision Oncology: A Festschrift in Honor of Kalevi Kairemo

Author(s): Oula Penate Medina* and Tuula Penate Medina

DOI: 10.2174/9781681088655122010024

Nanotheranostics: A Dream Coming True

Pp: 265-271 (7)

Buy Chapters

* (Excluding Mailing and Handling)

  • * (Excluding Mailing and Handling)

Abstract

SHS investigation development is considered from the geographical and historical viewpoint. 3 stages are described. Within Stage 1 the work was carried out in the Department of the Institute of Chemical Physics in Chernogolovka where the scientific discovery had been made. At Stage 2 the interest to SHS arose in different cities and towns of the former USSR. Within Stage 3 SHS entered the international scene. Now SHS processes and products are being studied in more than 50 countries.

Abstract

This chapter discusses how nanoparticles and multimodal nano-imaging are
bringing closer to the moment where imaging and therapy converge. This means that
the diagnosed illnesses can be treated in situ based on the imaging result allowing
personalized Nano-medicine. There are already theranostic nano-medicines that can do
precise drug delivery only to the targets that are seen and approved by radiology and
nuclear medicine tools. In this chapter, we also discuss the already existing emerging
techniques and their challenges and implications on the traditional pharma industry and
startup-driven biobusiness.

Recommended Chapters

We recommend

Favorable 70-S: Investigation Branching Arrow

Authors:Bentham Science Books